Search results
Results from the WOW.Com Content Network
The Global Appraisal of Individual Needs (GAIN) is a family of evidence-based instruments used to assist clinicians with diagnosis, placement, and treatment planning. The GAIN is used with both adolescents and adults in all kinds of treatment programs, including outpatient, intensive outpatient, partial hospitalization, methadone, short-term residential, long-term residential, therapeutic ...
Risk Evaluation and Mitigation Strategies (REMS) is a program of the US Food and Drug Administration for the monitoring of medications with a high potential for serious adverse effects. REMS applies only to specific prescription drugs, but can apply to brand name or generic drugs. [1] The REMS program was formalized in 2007.
It evaluates the cost-effectiveness of drugs in a similar way to the UK's NICE, [1] [3] and has come under some criticism from the drug industry. [2] ICER has placed a monetary value on several prescription drugs since 2014. Insurers have used those evaluations to justify which drugs are approved or denied.
The CRAFFT [1] is a short clinical assessment tool designed to screen for substance-related risks and problems in adolescents. CRAFFT stands for the key words of the 6 items in the second section of the assessment - Car, Relax, Alone, Forget, Friends, Trouble. As of 2020, updated versions of the CRAFFT known as the "CRAFFT 2.1" and "CRAFFT 2.1 ...
The patient care process is a cognitive process in which the drug-related needs of patients are approached systematically and comprehensively. "The patient care process, which must be consistent with the patient care processes of the other health care providers, consists of: an assessment of the patient's drug-related needs,
The ASI-5 survey contains a total of 164 items inquiring about the general background of the patients (n= 28), their conditions in the respective areas would be asked in the following according to the participants' preference on privacy recorded during the development of ASI: 1) Medical health (n= 11) 2) Employment/ support status (n= 24) 3 & 4) Drug/ alcohol use (n= 35) 5) Illegal activity ...
These medications were designated as specialty drugs and required specialty pharmacies. When the FDA approves a new drug they may require a REMS program which "may contain any combination of 5 criteria: Medication Guide, Communication Plan, Elements to Assure Safe Use, Implementation System, and Timetable for Submission of Assessments". [46 ...
FDA Building 51 is one of the main buildings in its White Oak campus that houses the Center for Drug Evaluation and Research. The Center for Drug Evaluation and Research (CDER, pronounced "see'-der") is a division of the U.S. Food and Drug Administration (FDA) that monitors most drugs as defined in the Food, Drug, and Cosmetic Act.